| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... N engl j Med 369, 111-121, 2013 | 1674 | 2013 |
| Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding HR Salih, HG Rammensee, A Steinle The Journal of Immunology 169 (8), 4098-4102, 2002 | 835 | 2002 |
| Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia HR Salih, H Antropius, F Gieseke, SZ Lutz, L Kanz, HG Rammensee, ... Blood 102 (4), 1389-1396, 2003 | 704 | 2003 |
| Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final … M Lübbert, S Suciu, L Baila, BH Rüter, U Platzbecker, A Giagounidis, ... Journal of clinical oncology 29 (15), 1987-1996, 2011 | 678 | 2011 |
| SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ... Nature immunology 22 (1), 74-85, 2021 | 625 | 2021 |
| Platelet-derived transforming growth factor-β down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity HG Kopp, T Placke, HR Salih Cancer research 69 (19), 7775-7783, 2009 | 546 | 2009 |
| Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group J Krönke, RF Schlenk, KO Jensen, F Tschürtz, A Corbacioglu, VI Gaidzik, ... Journal of Clinical Oncology 29 (19), 2709-2716, 2011 | 498 | 2011 |
| Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation RF Schlenk, S Kayser, L Bullinger, G Kobbe, J Casper, M Ringhoffer, ... Blood, The Journal of the American Society of Hematology 124 (23), 3441-3449, 2014 | 460 | 2014 |
| Natural killer cell–mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate S Armeanu, M Bitzer, UM Lauer, S Venturelli, A Pathil, M Krusch, S Kaiser, ... Cancer research 65 (14), 6321-6329, 2005 | 458 | 2005 |
| Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune CellsPlatelet MHC Class I Impairs … T Placke, M Örgel, M Schaller, G Jung, HG Rammensee, HG Kopp, ... Cancer research 72 (2), 440-448, 2012 | 454 | 2012 |
| Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the … U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ... Journal of Clinical Oncology 35 (6), 605-612, 2017 | 423 | 2017 |
| Spatial imagery in deductive reasoning: a functional MRI study M Knauff, T Mulack, J Kassubek, HR Salih, MW Greenlee Cognitive Brain Research 13 (2), 203-212, 2002 | 343 | 2002 |
| Soluble MICA in malignant diseases S Holdenrieder, P Stieber, A Peterfi, D Nagel, A Steinle, HR Salih International journal of cancer 118 (3), 684-687, 2006 | 339 | 2006 |
| Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ... Nature 572 (7768), 254-259, 2019 | 338 | 2019 |
| Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD RF Schlenk, D Weber, W Fiedler, HR Salih, G Wulf, H Salwender, ... Blood, The Journal of the American Society of Hematology 133 (8), 840-851, 2019 | 309 | 2019 |
| More than just tumor destruction: immunomodulation by thermal ablation of cancer SP Haen, PL Pereira, HR Salih, HG Rammensee, C Gouttefangeas Clinical and Developmental Immunology 2011, 2011 | 281 | 2011 |
| Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival MP Radsak, HR Salih, HG Rammensee, H Schild The Journal of Immunology 172 (8), 4956-4963, 2004 | 277 | 2004 |
| Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors PK Epling-Burnette, F Bai, JS Painter, DE Rollison, HR Salih, M Krusch, ... Blood, The Journal of the American Society of Hematology 109 (11), 4816-4824, 2007 | 268 | 2007 |
| High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses SK Metzelder, T Schroeder, A Finck, S Scholl, M Fey, K Götze, YC Linn, ... Leukemia 26 (11), 2353-2359, 2012 | 266 | 2012 |
| Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses J Hilpert, L Grosse-Hovest, F Grünebach, C Buechele, T Nuebling, ... The journal of immunology 189 (3), 1360-1371, 2012 | 256 | 2012 |
